[Superaspirin in the platelet aggregation inhibitor therapy].
Rossi
G
G
D000077284:Abciximab; D000085:Acetates / Q000008:administration & dosage / Q000494:pharmacology; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000494:pharmacology; D001241:Aspirin / Q000008:administration & dosage / Q000494:pharmacology; D005343:Fibrinolytic Agents; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage / Q000494:pharmacology; D016023:Integrins / Q000187:drug effects; D009203:Myocardial Infarction / Q000517:prevention & control; D009842:Oligopeptides / Q000008:administration & dosage / Q000494:pharmacology; D010456:Peptides, Cyclic / Q000008:administration & dosage / Q000494:pharmacology; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D012008:Recurrence; D013454:Sulfoxides / Q000008:administration & dosage / Q000494:pharmacology; D053778:Thiazolidines; D013997:Time Factors; D014443:Tyrosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology
D000085:Acetates; D000911:Antibodies, Monoclonal; D005343:Fibrinolytic Agents; D007140:Immunoglobulin Fab Fragments; D016023:Integrins; D009842:Oligopeptides; D010456:Peptides, Cyclic; D010975:Platelet Aggregation Inhibitors; D013454:Sulfoxides; D053778:Thiazolidines; C083231:MK 0852; C074915:G 4120; D014443:Tyrosine; C084062:lamifiban; D001241:Aspirin; D000077284:Abciximab
Le superaspirine nella terapia antiaggregante piastrinica.